MDM4 overexpression contributes to synoviocyte proliferation in patients with rheumatoid arthritis

Biochemical and Biophysical Research Communications

Volumn 401, Issue 3, 2010, Pages 417-421

  Xu, Nanwei ^a   Wang, Yuji ^a,b   Li, Dawei ^b   Chen, Guoqiang ^c   Sun, Rongbin ^a   Zhu, Ruixia ^a   Sun, Sai ^b   Liu, Hongwei ^a   Yang, Guang ^c   Dong, Tianhua ^d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

^d THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Fibroblast like synoviocytes; MDM4; Osteoarthritis; P53; Rheumatoid arthritis

Indexed keywords

LENTIVIRUS VECTOR; PROTEIN MDMX; PROTEIN P53;

ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST LIKE SYNOVIOCYTE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; WESTERN BLOTTING;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CELL PROLIFERATION; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; SYNOVIAL MEMBRANE; TUMOR SUPPRESSOR PROTEIN P53;

LENTIVIRUS;

EID: 77958150883     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.069     Document Type: Article

References (25)

1. Noss E.H., Brenner M.B. The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis. Immunol. Rev. 2008, 223:252-270.
2. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
3. Kruse J.P., Gu W. Modes of p53 regulation. Cell 2009, 137:609-722.
4. Tak P.P., Zvaifler N.J., Green D.R., Firestein G.S. Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol. Today 2000, 21:78-82.
5. Firestein G.S., Nguyen K., Aupperle K.R., Yeo M., Boyle D.L., Zvaifler N.J. Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am. J. Pathol. 1996, 149:2143-2151.
6. Reme T., Travaglio A., Gueydon E., Adla L., Jorgensen C., Sany J. Mutations of the p53 tumor suppressor gene in erosive rheumatoid synovial tissue. Clin. Exp. Immunol. 1998, 111:353-358.
7. Yamanishi Y., Boyle D.L., Rosengren S., Green D.R., Zvaifler N.J., Firestein G.S. Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. USA 2002, 99:10025-10030.
8. Seemayer C.A., Kuchen S., Neidhart M., Kuenzler P., Rihosková V., Neumann E., Pruschy M., Aicher W.K., Müller-Ladner U., Gay R.E., Michel B.A., Firestein G.S., Gay S. P53 in rheumatoid arthritis synovial fibroblasts at sites of invasion. Ann. Rheum. Dis. 2003, 62:1139-1144.
9. Taranto E., Xue J.R., Lacey D., Hutchinson P., Smith M., Morand E.F., Leech M. Detection of the p53 regulator murine double-minute protein 2 in rheumatoid arthritis. J. Rheumatol. 2005, 32:424-429.
10. Yagishita N., Yamasaki S., Nishioka K., Nakajima T. Synoviolin, protein folding and the maintenance of joint homeostasis. Nat. Clin. Pract. Rheumatol. 2008, 4:91-97.
11. Shao L., Fujii H., Colmegna I., Oishi H., Goronzy J.J., Weyand C.M. Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J. Exp. Med. 2009, 206:1435-1449.
12. Mancini F., Di Conza G., Moretti F. MDM4 (MDMX) and its transcript variants. Curr. Genomics 2009, 10:42-50.
13. Marine J.C., Dyer M.A., Jochemsen A.G. Mdm4: from bench to bedside. J. Cell Sci. 2007, 120:371-378.
14. Marine J.C., Francoz S., Maetens M., Wahl G., Toledo F., Lozano G. Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ. 2006, 13:927-934.
15. Parant J., Chavez-Reyes A., Little N.A., Yan W., Reinke V., Jochemsen A.G., Lozano G. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with Mdm2 to regulate p53. Nat Genet 2001, 29:92-95.
16. Jin Y., Zeng S.X., Sun X.X., Lee H., Blattner C., Xiao Z., Lu H. MDMX promotes proteasomal turnover of p21 at G1 and early S phases independently of, but in cooperation with, Mdm2. Mol. Cell. Biol. 2008, 28:1218-1229.
17. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., Healey L.A., Kaplan S.R., Liang M.H., Luthra H.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31:315-324.
18. Bartel F., Schulz J., Böhnke A., Blümke K., Kappler M., Bache M., Schmidt H., Würl P., Taubert H., Hauptmann S. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis. Int. J. Cancer 2005, 117:469-475.
19. Hu B., Gilkes D.M., Farooqi B., Sebti S.M., Chen J. Mdm4 overexpression prevents p53 activation by the Mdm2 inhibitor Nutlin. J. Biol. Chem. 2006, 281:33030-33035.
20. Barkan D., Kleinman H., Simmons J.L., Asmussen H., Kamaraju A.K., Hoenorhoff M.J., Liu Z.Y., Costes S.V., Cho E.H., Lockett S., Khanna C., Chambers A.F. Green JE. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 2008, 68:6241-6250.
21. Tak P.P., Smeets T.J., Boyle D.L., Kraan M.C., Shi Y., Zhuang S., Zvaifler N.J., Breedveld F.C., Firestein G.S. P53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum. 1999, 42:948-953.
22. Gilkes D.M., Pan Y., Coppola D., Yeatman T., Reuther G.W., Chen J. Regulation of Mdm4 expression by mitogenic signaling. Mol. Cell. Biol. 2008, 28:1999-2010.
23. Lacey D., Sampey A., Mitchell R., Bucala R., Santos L., Leech M., Morand E. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum. 2003, 48:103-109.
24. Migliorini D., Lazzerini Denchi E., Danovi D., Jochemsen A., Capillo M., Gobbi A., Helin K., Pelicci P.G., Marine J.C. Mdm4 (Mdm4) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. Mol. Cell. Biol. 2002, 22:5527-5538.
25. Xiong S., Van Pelt C.S., Elizondo-Fraire A.C., Liu G., Lozano G. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proc. Natl. Acad. Sci. USA 2006, 103:3226-3231.